349 related articles for article (PubMed ID: 33514440)
1. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.
Zhu M; Liang Q; Chen T; Kong Q; Ye G; Yu S; Li X; He Q; Liu H; Hu Y; Yu J; Li G
Clin Epigenetics; 2021 Jan; 13(1):22. PubMed ID: 33514440
[TBL] [Abstract][Full Text] [Related]
2. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
[TBL] [Abstract][Full Text] [Related]
3. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
[TBL] [Abstract][Full Text] [Related]
4. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway.
Dong M; Gong LP; Chen JN; Zhang XF; Zhang YW; Hui DY; Zhao XX; Wu XY; Shao CK
Cell Oncol (Dordr); 2020 Oct; 43(5):901-913. PubMed ID: 32533512
[TBL] [Abstract][Full Text] [Related]
5. Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation.
Jing JJ; Wang ZY; Li H; Sun LP; Yuan Y
Cancer Cell Int; 2018; 18():146. PubMed ID: 30258285
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.
Wang J; Zheng X; Qin Z; Wei L; Lu Y; Peng Q; Gao Y; Zhang X; Zhang X; Li Z; Fu Y; Liu P; Liu C; Yan Q; Xiong W; Li G; Lu J; Ma J
J Biol Chem; 2019 Mar; 294(13):4854-4866. PubMed ID: 30674552
[TBL] [Abstract][Full Text] [Related]
7. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
8. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Fukayama M; Kunita A; Kaneda A
Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
[TBL] [Abstract][Full Text] [Related]
10. Aberrantly methylated-differentially expressed genes and pathways in Epstein-Barr virus-associated gastric cancer.
Jing JJ; Li H; Wang ZY; Zhou H; Sun LP; Yuan Y
Future Oncol; 2020 Feb; 16(6):187-197. PubMed ID: 31989840
[No Abstract] [Full Text] [Related]
11. Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3.
Park MC; Kim H; Choi H; Chang MS; Lee SK
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681596
[TBL] [Abstract][Full Text] [Related]
12. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.
Okada T; Nakamura M; Nishikawa J; Sakai K; Zhang Y; Saito M; Morishige A; Oga A; Sasaki K; Suehiro Y; Hinoda Y; Sakaida I
Cancer Sci; 2013 Oct; 104(10):1309-14. PubMed ID: 23829175
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract][Full Text] [Related]
15. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
Zhang C; Zou Y; Dai DQ
Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
[TBL] [Abstract][Full Text] [Related]
18. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Prognostic Values of CXCL Family in Epstein-Barr Virus Associated Gastric Cancer.
Mu L; Hu S; Li G; Wu P; Ren C; Lin T; Zhang S
Oxid Med Cell Longev; 2022; 2022():2218140. PubMed ID: 35693706
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
